196 related articles for article (PubMed ID: 23656526)
1. Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.
Bagramyan K; Kaplan BE; Cheng LW; Strotmeier J; Rummel A; Kalkum M
Anal Chem; 2013 Jun; 85(11):5569-76. PubMed ID: 23656526
[TBL] [Abstract][Full Text] [Related]
2. Enhancing toxin-based vaccines against botulism.
Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
[TBL] [Abstract][Full Text] [Related]
3. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
5. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
Tepp WH; Lin G; Johnson EA
Appl Environ Microbiol; 2012 May; 78(9):3108-13. PubMed ID: 22367089
[TBL] [Abstract][Full Text] [Related]
7. An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin.
Evans ER; Skipper PJ; Shone CC
J Appl Microbiol; 2009 Oct; 107(4):1384-91. PubMed ID: 19426271
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
9. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
Schmidt JJ; Stafford RG
Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
Kukreja RV; Sharma SK; Singh BR
Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
[TBL] [Abstract][Full Text] [Related]
11. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.
Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR
J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544
[TBL] [Abstract][Full Text] [Related]
12. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
13. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies to type A, B, E and F botulinum neurotoxins].
Abbasova SG; Ruddenko NV; Gorokhovatskiĭ AIu; Kapralova MV; Vinogradova ID; Vertiev IuV; Nesmeianov VA; Grishin EV
Bioorg Khim; 2011; 37(3):344-53. PubMed ID: 21899049
[TBL] [Abstract][Full Text] [Related]
16. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E.
Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R
Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524
[TBL] [Abstract][Full Text] [Related]
17. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
18. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Dolimbek BZ; Jankovic J; Atassi MZ
Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
[TBL] [Abstract][Full Text] [Related]
19. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
20. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
Pellett S; Tepp WH; Johnson EA; Sesardic D
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
